Market Overview

The Global Malaria Diagnostics Market was valued at USD 840.1 million in 2023 and is expected to reach USD 1,250.6 million by 2031 while growing at a CAGR of 5.1% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global malaria diagnostics market growth. Malaria diagnostics involve detecting and diagnosing the disease caused by Plasmodium parasites transmitted by infected Anopheles mosquitoes. Early and accurate diagnosis is essential for timely treatment, preventing severe complications and death.

Continuous advancements in malaria diagnostic technologies, including rapid diagnostic tests (RDTs) and molecular assays like PCR, alongside prevention and elimination efforts, propel the malaria diagnostics market forward. Nonetheless, antimalarial drug resistance and weaknesses in health systems could impede market growth.

Furthermore, the global malaria diagnostics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Technology Analysis

The Global Malaria Diagnostics Market is segmented among Clinical Diagnostics, Microscopic Diagnostics, Rapid Diagnostic Tests, Molecular Diagnostics, and Other Technologies, based on Technology. In 2023, Rapid Diagnostic Tests (RDTs) accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Malaria Diagnostics Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, Africa dominated the market with the highest market share, while Latin America is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Access Bio Inc., Abbott Laboratories, BioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Premier Medical Corporation Pvt. Ltd, Siemens Healthineers, Bio-Rad Laboratories Inc., Nikon Corporation, and Advy Chemical Pvt Ltd

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Malaria Diagnostics Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Malaria Diagnostics Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Malaria Diagnostics Market Segmentation, By Technology

• Global Malaria Diagnostics Market Share Analysis, By Technology

• Global Malaria Diagnostics Market Growth Analysis, By Technology

• Global Malaria Diagnostics Market Trends, By Technology

o Clinical Diagnostics

o Microscopic Diagnostics

o Rapid Diagnostic Tests

o Molecular Diagnostics

o Other Technologies

6. Global Malaria Diagnostics Market Segmentation, By Region

• Global Malaria Diagnostics Market Share Analysis, By Region

• Global Malaria Diagnostics Market Growth Analysis, By Region

• Global Malaria Diagnostics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

7. Competitive Landscape

• Access Bio Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Abbott Laboratories

• BioMerieux SA

• Ortho Clinical Diagnostics

• Thermo Fisher Scientific

• Premier Medical Corporation Pvt. Ltd

• Siemens Healthineers

• Bio-Rad Laboratories Inc.

• Nikon Corporation

• Advy Chemical Pvt Ltd

*Similar analysis will be provided for each company listed above.